Shagun Singh of RBC Capital, Reiterated "Abbott Laboratories" (ABT) at Buy and Held Target at $125 on, Jun 4th, 2024.
Shagun has made no other calls on ABT in the last 4 months.
There are 5 other peers that have a rating on ABT. Out of the 5 peers that are also analyzing ABT, 0 agree with Shagun's Rating of Hold.
These are the ratings of the 5 analyists that currently disagree with Shagun
- David Roman of "Goldman Sachs" Initiated at Strong Buy and Held Target at $121 on, Thursday, May 30th, 2024
- Joanna Wiensch of "Citigroup" Maintained at Strong Buy with Decreased Target to $119 on, Wednesday, May 22nd, 2024
- Matt Miksic of "Barclays" Maintained at Buy with Decreased Target to $140 on, Monday, April 22nd, 2024
- Vijay Kumar of "Evercore ISI Group" Maintained at Buy with Increased Target to $125 on, Thursday, April 4th, 2024
- Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Increased Target to $128 on, Wednesday, April 3rd, 2024
